Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Amortizatization of Intangibles of -$117778.9 for Q1 2025, down 234.5% year-over-year from $87569.4 in Q1 2024, and down 233.76% quarter-over-quarter from $88049.4 in Q4 2024.
Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Amortizatization of Intangibles for 9 consecutive years, with -$117778.9 the latest figure, recorded in Q1 2025.
- In Q1 2025, Amortizatization of Intangibles fell 234.5% year-over-year to -$117778.9; the TTM figure through Mar 2025 stood at $234698.2 (down 96.62% YoY), while the FY2026 annual figure was $589198.2, up 160.02% from the prior year.
- Amortizatization of Intangibles fell to -$117778.9 in Q1 2025 per ACB's latest filing, from $88049.4 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $8.8 million in Q2 2021 and bottomed at -$117778.9 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $3.7 million across 5 years, with a median of $6.5 million in 2022.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles grew 28.95% — and 2025, when it sank 234.5%.
- Aurora Cannabis' Amortizatization of Intangibles stood at $6.7 million in 2021, then fell by 2.95% to $6.5 million in 2022, then plunged by 97.0% to $193917.4 in 2023, then plunged by 54.59% to $88049.4 in 2024, then slumped by 233.76% to -$117778.9 in 2025.
- Business Quant data shows ACB's Amortizatization of Intangibles at -$117778.9 in Q1 2025, $88049.4 in Q4 2024, and $186195.6 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | 67,232.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -117,778.88 |
| Mar 31, 2025 | -117,778.88 |
| Dec 31, 2024 | 88,049.44 |
| Dec 31, 2024 | 88,049.44 |
| Sep 30, 2024 | 186,195.57 |
| Sep 30, 2024 | 186,195.57 |
| Jun 30, 2024 | 78,232.04 |
| Jun 30, 2024 | 78,232.04 |
| Mar 31, 2024 | 87,569.36 |
| Mar 31, 2024 | 87,569.36 |
| Dec 31, 2023 | 193,917.38 |
| Dec 31, 2023 | 193,917.38 |
| Sep 30, 2023 | 204,384.95 |
| Sep 30, 2023 | 204,384.95 |
| Dec 31, 2022 | 6.46 Mn |
| Dec 31, 2022 | 6.46 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.52 Mn |